First Light Asset Management, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
First Light Asset Management, LLC disclosed 38 US equity positions worth $771.3m in its Q2 2025 13F filing. The largest position was ANAB at 10.2% of the reported book, followed by CNTA and PFMTUSD. Against the Q1 2025 filing, it opened 8 new positions, added to 11 and reduced 19 among the top 38 holdings.
What did First Light Asset Management, LLC own in Q2 2025? Top 38 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | ANAB ANAPTYS BIO INC | Healthcare | 10.2% | $78.6m | 3,539,593 | -24% | reduced |
| 2 | CNTA CENTESSA PHARMACEUTICALS LIMITED | 7.3% | $56.4m | 4,293,411 | -12% | reduced | |
| 3 | PFMTUSD PERFORMANT HEALTHCARE INC | 6.8% | $52.7m | 13,170,381 | 13% | added | |
| 4 | NEO NEOGENOMICS INC | Healthcare | 6.5% | $50.0m | 6,846,432 | 13% | added |
| 5 | AXGN AXOGEN INC | Healthcare | 6.4% | $49.1m | 4,529,243 | 1% | added |
| 6 | HCAT HEALTH CATALYST INC | Healthcare | 6.0% | $46.1m | 12,230,181 | 17% | added |
| 7 | TWST TWIST BIOSCIENCE CORPORATION | Healthcare | 4.5% | $34.8m | 945,033 | -22% | reduced |
| 8 | ATRC ATRICURE INC | Healthcare | 4.3% | $33.3m | 1,015,170 | -23% | reduced |
| 9 | SIBN SI-BONE INC | Healthcare | 4.3% | $33.0m | 1,751,001 | 9% | added |
| 10 | IRTC IRHYTHM TECHNOLOGIES | Healthcare | 3.7% | $28.8m | 187,355 | -42% | reduced |
| 11 | CRNXGBP CRINETICS PHARMACEUTICALS INC | 3.2% | $24.9m | 864,136 | 1% | added | |
| 12 | ORGO ORGANOGENESIS HOLDINGS INC | Healthcare | 3.2% | $24.8m | 6,777,163 | – | new |
| 13 | EWTX EDGEWISE THERAPEUTICS INC | 2.9% | $22.5m | 1,714,019 | -7% | reduced | |
| 14 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 2.6% | $19.9m | 547,905 | -13% | reduced |
| 15 | ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 2.3% | $17.8m | 417,157 | 24% | added |
| 16 | ADMA ADMA BIOLOGICS INC | Healthcare | 2.2% | $17.3m | 952,096 | – | new |
| 17 | SENS SENSEONICS HOLDINGS INC | Healthcare | 2.2% | $17.0m | 35,708,124 | 667% | added |
| 18 | KRMD KORU MEDICAL SYSTEMS INC | 2.2% | $16.8m | 4,681,626 | 5% | added | |
| 19 | NPCE NEUROPACE INC | 2.0% | $15.4m | 1,380,410 | -13% | reduced | |
| 20 | VERA VERA THERAPEUTICS INC | Healthcare | 1.7% | $13.3m | 562,981 | -52% | reduced |
| 21 | MDXG MIMEDX GROUP INC | Healthcare | 1.5% | $11.8m | 1,927,494 | -44% | reduced |
| 22 | CAI CARIS LIFE SCIENCES INC | Healthcare | 1.5% | $11.2m | 443,043 | – | new |
| 23 | BFLY BUTTERFLY NETWORK INC | 1.4% | $10.9m | 5,465,032 | -1% | reduced | |
| 24 | CDTX CIDARA THERAPEUTICS INC | 1.1% | $8.8m | 180,615 | – | new | |
| 25 | EVH EVOLENT HEALTH INC | Healthcare | 1.1% | $8.3m | 738,550 | 26% | added |
| 26 | MASS 908 DEVICES INC | 1.0% | $7.6m | 1,067,613 | -37% | reduced | |
| 27 | ELDN ELEDON PHARMACEUTICALS INC | 0.9% | $7.0m | 2,600,498 | 12% | added | |
| 28 | GH GUARDANT HEALTH | Healthcare | 0.9% | $6.7m | 128,868 | -52% | reduced |
| 29 | INSM INSMED INC | Healthcare | 0.8% | $6.3m | 62,901 | -8% | reduced |
| 30 | SLP SIMULATIONS PLUS INC | Healthcare | 0.8% | $6.2m | 357,157 | – | new |
| 31 | XENE XENON PHARMACEUTICALS | Healthcare | 0.8% | $5.9m | 188,367 | -70% | reduced |
| 32 | RGEN REPLIGEN CORP | Healthcare | 0.7% | $5.5m | 43,949 | -50% | reduced |
| 33 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 0.7% | $5.4m | 383,663 | -60% | reduced |
| 34 | EOLS EVOLUS INC | Healthcare | 0.6% | $4.8m | 520,631 | – | new |
| 35 | RDNT RADNET INC | Healthcare | 0.5% | $3.9m | 68,694 | – | new |
| 36 | JANX JANUX THERAPEUTICS INC | Healthcare | 0.4% | $3.5m | 149,596 | -77% | reduced |
| 37 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.3% | $2.5m | 122,226 | -8% | reduced |
| 38 | LNTH LANTHEUS HOLDINGS INC | Healthcare | 0.3% | $2.5m | 30,045 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.